Teva Pharmaceutical: Behind the Numbers: Working To Tackle Breast Cancer in Ghana
NORTHAMPTON, MA / / February 25, 2025 / Breast cancer remains a significant health challenge globally with approximately 2.3M new cases in 20221. While breast cancer deaths continue to ...
Teva Pharmaceutical Industries Limited (TEVA): Among Bourgeon Capital’s Top Stock Picks
We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take ...
Behind the Numbers: Working To Tackle Breast Cancer in Ghana
NORTHAMPTON, MA / ACCESS Newswire / February 25, 2025 / Breast cancer remains a significant health challenge globally with ...
Piper Sandler Sticks to Its Buy Rating for Teva Pharmaceutical (TEVA)
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
PharmiWeb14h
Formycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE®
Regulatory ApprovalFormycon receives regulatory approval in the UK for FYB203 (aflibercept), a biosimilar to Eylea®, under the brand name AHZANTIVE® 25.02.2025 / 06:30 CET/CESTThe issuer is solely ...